Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety of intravenous infusion of cultured allogeneic umbilical cord-derived mesenchymal stem cells in chronic kidney disease. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Cultured allogeneic adult umbilical cord-derived mesenchymal stem cells (intravenous infusion)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Chronic Kidney Diseases | Phase 1 | Status: RECRUITING